After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
Biocryst Pharmaceuticals Inc is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Drug Manufacturers – Specialty & Generic industry. The current market capitalization of Biocryst Pharmaceuticals Inc is $1.65B. A total of 6.71 million shares were traded on the day, compared to an average of 4.80M shares.
In the most recent transaction, Barnes Alane P sold 91,004 shares of BCRX for 7.10 per share on Dec 01 ’25. After the transaction, the Chief Legal Officer now owns 416,152 company shares. In a previous transaction on Dec 02 ’25, Barnes Alane P sold 50,906 shares at 7.21 per share. BCRX shares that Chief Legal Officer owns now total 365,246.
Among the insiders who sold shares, Barnes Alane P disposed of 19,770 shares on Dec 03 ’25 at a per-share price of $7.65. This resulted in the Chief Legal Officer holding 345,476 shares of BCRX after the transaction. In another insider transaction, Barnes Alane P bought 19,770 shares at $7.65 per share on Dec 03 ’25.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, BCRX has a high of $11.31 and a low of $6.00.
As of this writing, BCRX has an earnings estimate of $0.03 per share for the current quarter. EPS was calculated based on a consensus of 4.0 estimates, with a high estimate of $0.06 per share and a lower estimate of $0.0. The company reported an EPS of -$0.13 in the last quarter
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. BCRX’s latest balance sheet shows that the firm has $507.60M in Cash & Short Term Investments as of fiscal 2021. There were $593.24M in debt and $103.72M in liabilities at the time. Its Book Value Per Share was -$1.84, while its Total Shareholder’s Equity was -$106.99M.
Analysts Opinion
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for BCRX is Buy with a score of 4.45.
